mastalgia pubmed ncbi abstract objective review current management women breast pain options effect treatment modes health practices including medications considered management cyclical noncyclical breast pain outcomes effective timely management woman breast pain improved quality life evidence literature search performed identify reports published english num july num medline cochrane database systematic reviews values levels evidence outlined determined criteria outlined canadian task force periodic health examination participants principal authors clinical dietitian surgeon oncologist nurse benefits harms costs utilizing information increase knowledge enabling consistent approach reduce number ineffective interventions ensure medications validation comparison made management protocols literature clinical guidelines located formal clinical testing place sponsor society obstetricians gynaecologists canada sogc work guidelines initiated team members fill practice guidelines winnipeg regional health authority breast health centre winnipeg mb recommendations num education reassurance integral part management mastalgia first-line treatment ii num num well-fitting bra good support considered relief cyclical noncyclical mastalgia ii num num change dose formulation scheduling considered women hrt hrt discontinued iii num women breast pain advised reduce caffeine intake num num vitamin considered treatment mastalgia num num presently insufficient evidence recommend evening primrose oil epo treatment breast pain ii num num flaxseed considered first-line treatment cyclical mastalgia num topical non-steroidal anti-inflammatory gel diclofenac num pluronic lethicin organogel considered pain control localized treatment mastalgia num tamoxifen num mg daily danazol num mg daily considered first-line treatments ineffective num mastectomy partial mastectomy considered effective treatment mastalgia iii 
